title: Posttransplant anti-HLA antibodies: risk factor for chronic rejection?
authors.affiliation: Néphrologie-Immunologie Clinique, CHU TOURS, France.
authors.forename: M
authors.initials: M
authors.lastname: Buchler
authors.forename: A
authors.initials: A
authors.lastname: al Najjar
authors.forename: A
authors.initials: A
authors.lastname: Guerraoui
authors.forename: J F
authors.initials: JF
authors.lastname: Valentin
authors.forename: M D
authors.initials: MD
authors.lastname: Boulanger
authors.forename: R
authors.initials: R
authors.lastname: Sherobeen
authors.forename: A
authors.initials: A
authors.lastname: Lataste
authors.forename: H
authors.initials: H
authors.lastname: Nivet
authors.forename: Y
authors.initials: Y
authors.lastname: Lebranchu
mesh_terms: D000917:Antibody Formation; D016009:Chi-Square Distribution; D003404:Creatinine / Q000097:blood; D003602:Cytotoxicity, Immunologic; D006084:Graft Rejection / Q000175:diagnosis / Q000453:epidemiology / Q000276:immunology*; D006680:HLA Antigens / Q000276:immunology*; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D012189:Retrospective Studies; D012307:Risk Factors; D013997:Time Factors
chemical_list: D006680:HLA Antigens; D003404:Creatinine